These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 766074)
1. Critical evaluation of platelet-inhibiting drugs in thrombotic disease. Harker LA; Hirsh J; Gent M; Genton E Prog Hematol; 1975; 9():229-54. PubMed ID: 766074 [No Abstract] [Full Text] [Related]
2. Platelet inhibitors in the treatment of thrombosis. Hirsh J Clin Invest Med; 1978; 1(3-4):191-206. PubMed ID: 391458 [No Abstract] [Full Text] [Related]
3. The current status of platelet suppressive drugs in the treatment of thrombosis. Hirsh J; Gent M; Genton E Thromb Diath Haemorrh; 1975 Jun; 33(3):406-16. PubMed ID: 1098213 [No Abstract] [Full Text] [Related]
4. Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (first of three parts). Genton E; Gent M; Hirsh J; Harker LA N Engl J Med; 1975 Dec; 293(23):1174-8. PubMed ID: 1102977 [No Abstract] [Full Text] [Related]
8. Antiplatelet drugs in the management of patients with thrombotic disorders. Harker LA Semin Thromb Hemost; 1986 Apr; 12(2):134-55. PubMed ID: 3016905 [No Abstract] [Full Text] [Related]
9. [Treatment with antiplatelet drugs. Current status of knowledge]. Dettori AG; Pini M; Quintavalla R Recenti Prog Med; 1979 Sep; 67(3):346-67. PubMed ID: 392656 [No Abstract] [Full Text] [Related]
10. Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells. Turpie AG Prog Clin Biol Res; 1982; 89():31-62. PubMed ID: 7051035 [TBL] [Abstract][Full Text] [Related]
11. Drugs in the treatment of thrombo-embolic disease--part I. Bouchier-Hayes D Ir Med J; 1983 Feb; 76(2):101-5, 107. PubMed ID: 6601642 [No Abstract] [Full Text] [Related]
12. A perspective on platelet-suppressant drug treatment in coronary artery and cerebrovascular disease. Genton E Circulation; 1980 Dec; 62(6 Pt 2):V111-21. PubMed ID: 6108166 [No Abstract] [Full Text] [Related]
13. Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (third of three parts). Genton E; Gent M; Hirsh J; Harker LA N Engl J Med; 1975 Dec; 293(25):1296-300. PubMed ID: 1102986 [No Abstract] [Full Text] [Related]
14. Use of common antiplatelet drugs for vascular diseases. Pagano T; Nair CK; Sketch MH Geriatrics; 1983 Nov; 38(11):75-95. PubMed ID: 6605278 [No Abstract] [Full Text] [Related]
15. A critical appraisal of the clinical efficiency of anti-platelet drugs. Lecompte T; Samama M Agents Actions Suppl; 1986; 20():203-14. PubMed ID: 3544741 [No Abstract] [Full Text] [Related]
16. [Critical evaluation of the usefulness of drugs inhibiting platelet function in the prevention of postoperative deep venous thrombosis and in ischemic cardiopathy]. Verstraete M Recenti Prog Med; 1980 Apr; 68(4):361-81. PubMed ID: 6992244 [No Abstract] [Full Text] [Related]
17. Drug therapy: antiplatelet therapy (second of two parts). Weiss HJ N Engl J Med; 1978 Jun; 298(25):1403-6. PubMed ID: 349388 [No Abstract] [Full Text] [Related]
18. Effect of prostaglandin-mediated platelet-suppressant drugs on acute cardiovascular catastrophes. Sherry S Adv Prostaglandin Thromboxane Leukot Res; 1982; 10():173-210. PubMed ID: 6216782 [No Abstract] [Full Text] [Related]